Altergon logo white
Hyaluronic acid drop Hyaluronic acid background


High quality Hyaluronic Acid
suitable for pharmaceutical, medical
and dermocosmetic industries

see more
Cerotti medicati Hydrogel Cerotti medicati background Cerotti medicati background 2


Innovative technology for release
of active ingredients
for topical and transdermal use

see more
Shyalt Ultrapure Acido Ialuronico Shyalt Ultrapure drops
Shyalt Ultrapure


from Altergon Italia R&D laboratories
the new frontier of Hyaluronic Acid

see more


"In Altergon we work steadily to increase the safety and efficacy of our products, to improve the quality of our patients life”

Our strength is in combining the strict respect of the rules and ethical principles that govern the production of the drug, with the focus on innovation and scientific research

see more


Un'innovativa C.D.M.O.-Contract Development & Manufacturing Organization- per proporre moderni sistemi di Drug Delivery alle società clienti.

  • Production of medicated and transdermal patch – Drug in Adhesive
  • Formulation and production of Hydrogel medicated plasters
  • Biotech production of Ultra Pure Hyaluronic Acid
  • Secondary packaging and pharmaceutical warehouse
  • Medical Device Production
  • QC Analysis and QP release certifications
see more
Prodotti e servizi Altergon 1
Prodotti e servizi Altergon 2
Prodotti e servizi Altergon 3
Prodotti e servizi Altergon 4


We are proud to inform you that the Altergon Ultrapure EP Sodium Hyaluronate bulk (API) has been registered at the Ministry of Health of the Russian Federation. The information is available on the website of the Russian Ministry of Health under the entry number FS-001899.

Our Identity, Your Success !

Research between Market and Innovation

Opportunities for the territory
March 29, 2019 at "Sala Blu - Palazzo San Domenico - Università dal Sannio", Piazza Guerrazzi 1, Benevento

INAIL Safap 2018 - Contributo Altergon

Si è svolta a Bologna nei giorni 28 e 29 novembre l'edizione 2018 del SAFAP Sicurezza e Affidabilità delle Attrezzature a Pressione, un convegno organizzato da INAIL che quest'anno trattava il tema de "La gestione del rischio dalla costruzione all'esercizio a 120 anni dal primo decreto sulla sicurezza delle caldaie a vapore". La memoria " La Valutazione del Rischio ATEX conseguente all’utilizzo dell’etanolo nel ciclo di produzione dell’acido ialuronico", scritta congiuntamente da INAIL Avellino e Altergon , è stata presentata con interesse nella sezione poster.

Poster Evento


In March 2016, Altergon submitted to FDA (CDRH) the Master File for manufacturing Sodium Hyaluronate (MAF)

CEP - Certificate of Suitability

Altergon Italia is pleased to inform that our Ultrapure Hyaluronate successfully succeeded the Certificate of Suitability (CEP: R0-CEP 2014-263-Rev 00) to the European Pharmacopoeia, Sodium Hyaluronate Monograph granted by the EDQM.

Singularity and innovation

From start-up to European leader in producing transdermal medicines
pag. 73 Platinum July 2015

New Altergon Italia patent: Cold Hot patch


Meet Altergon at CPhI Festival of Pharma from 5-16 October, the global innovative pharmaceutical digital event of 2020, during which you can be connected with us. Sign up for free and let’s start it!
Our Identity, Your Success!
Visit us on and
#Altergon #CPhI #CPhI2020 #CPhIonline #HyaluronicAcid #SodiumHyaluronate #Shyalt #CPhIFestivalofPharma
Altergon Italia exhibitor at CPhI Festival of Pharma